-
US indices finished yesterday's session lower but off the daily lows. S&P 500 closed 0.15% lower, Nasdaq declined 0.47% and Dow Jones slipped 0.07%. Russell 2000 gained 0.98%
-
Bears dominate during the Asian session. Nikkei trades 0.3% lower, S&P/ASX 200 declines 0.5% and Kospi drops 1%. Indices from China trade mixed
-
DAX futures point to a higher opening of the European session
-
Almost 400 thousand new coronavirus cases were reported yesterday. Death toll has exceeded 1.1 million while total case count stands at 39.1 million. 29.3 million people recovered
-
According to Financial Times, WHO study found out that Remdesivir has little impact on Covid mortality. In other news, Japanese Fujifilm is proceeding with getting approval for its coronavirus drug Avigan
-
Mnuchin said that if he reaches deal with Pelosi, Trump will convince Senate Majority leader McConnell to back it
-
Dutch Prime Minister Rutte said that United Kingdom needs to do more if it wants to reach a Brexit trade deal. Merkel said that progress was made but some issues remain
-
According to Australian media, China has asked domestic companies to stop buying cotton from Australia
-
Some Democrats working on Biden campaign contracted Covid-19. However, both Biden and Harris have tested negative
-
EUR and JPY are top moving majors while AUD and NZD are top laggards. EM currencies trade lower against USD
-
Oil is pulling back slightly after a very volatile trading yesterday
Another daily record has been set - almost 400 thousand new coronavirus cases. Source: worldometers, XTB
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
